This compound is a purine derivative used as a pharmaceutical intermediate in the manufacturing process of linagliptin. It contains aromatic ring systems and a halogen substituent, consistent with its role in specialized chemical synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-(Chloromethyl)-4-methylquinazoline
pharmaceutical intermediate
(S)-3,3-DIMETHYL-2-(2,2,2-TRIFLUOROACETAMIDO)BUTANOIC ACID
pharmaceutical intermediate
2,3,5-Trifluoronitrobenzene
pharmaceutical intermediate
2,3-Difluoro-6-nitroanisole
pharmaceutical intermediate
[[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]methyl]oxirane
pharmaceutical intermediate
8-bromo-7-but-2-ynyl-3-methylpurine-2,6-dione
HFZOBQSHTNNKFY-UHFFFAOYSA-N
CC#CCN1C2=C(N=C1Br)N(C(=O)NC2=O)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.